A Novel in-vivo Assay System for Screening and Validation of Drugs
Implementing Organization
National Research Development Corporation (NRDC), New Delhi
About
The development is an assay system with novel features such as: (i) Using Drosophila for the first time as a model to screen drugs against human colon cancer; (ii) An alternative genetic model system to transgenic mice system; (iii) Inexpensive, faster and easy to use genetic system; (iv) Enables studies of toxic effects of the drugs over a number of generations due to short life cycle of the fly; (v) Drug-target interactions in the transgenic files allows the identification of the new genes and drug target system. Until recently mouse has been the model system to study human physiology, biochemistry, diseases, etc. However, with the identification of increasing number of genes causing human diseases, it is becoming important to develop alternative genetic models to study the basic gene functions at lesser costs.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.